click below
click below
Normal Size Small Size show me how
Pain, Hema, Onc 1
| Pharmacologic Category | Generic | Brand | Classification | Common Indication | Key Side effects | US Boxed warning | Other notes |
|---|---|---|---|---|---|---|---|
| Opioid analgesic | fentanyl (transdermal, IV) | Transdermal: Duragesic, IV: Sublimaze | CS-II | Pain | dizziness, drowsiness, nausea, vomiting, constipation, pruritus, respiratory depression (dose-related) | (see BDK for the rest) potential for medication errors when converting between dosage forms; use with CYP3A4 inhibitors (or stopping CYP3A4 inducers) can increase fentanyl concentrations; avoid exposing transdermal patch to external heat | n/a |
| Opioid analgesic | hydromorphone (PO, IV) | Dilaudid | CS-II | Pain | dizziness, drowsiness, nausea, vomiting, constipation, pruritus, respiratory depression (dose-related) | (see BDK for the rest) risk of medication errors with high-potency hydromorphone, use in opioid-tolerant patients only | n/a |
| Opioid analgesic | morphine (extended release) (PO) | MS Contin, Kadian | CS-II | Pain | dizziness, drowsiness, nausea, vomiting, constipation, pruritus, respiratory depression (dose-related) | (see BDK for the rest) coingestion with alcohol may result in potentially fatal overdose of morphine | n/a |
| Opioid analgesic | morphine (immediate release) (PO, IV, IM, PR) | IV: Duramorph, Infumorph | CS-II | Pain | dizziness, drowsiness, nausea, vomiting, constipation, pruritus, respiratory depression (dose-related) | See BDK for big US boxed warning | n/a |
| Opioid analgesic | oxycodone (PO) | OxyContin, Roxicodone | CS-II | Pain | dizziness, drowsiness, nausea, vomiting, constipation, pruritus, respiratory depression (dose-related) | (see BDK for the rest) use with CYP3A4 inhibitors (or stopping CYP3A4 inducers) can increase oxycodone concentrations | n/a |
| Opioid analgesic | methadone (PO, IV) | Dolophine | CS-II | Opioid use disorder, severe chronic pain | dizziness, drowsiness, nausea, vomiting, constipation, respiratory depression (dose-related), QTc prolongation | (see BDK for the rest) QTc interval prolongation and serious arrhythmia (Torsades de Pointes) have occurred during treatment; concomitant use with CYP3A4, 2B6, 2C19, or 2D6 (or stopping the same inducers) can increase methadone concentrations | n/a |
| Analgesic (non- opioid), antipyretic | acetaminophen (PO, PR, IV) | PO/PR: Tylenol, IV: Ofirmev | PO, PR: OTC | Pain, fever | nausea, vomiting, increased hepatic transaminases | total daily dose from all sources should not exceed maximum daily limit; hepatotoxicity | n/a |
| Central analgesic; partial opioid agonist | tramadol (PO) | Ultram, Ultram ER | CS-IV | Pain | dizziness, drowsiness, nausea, vomiting, constipation, respiratory depression (dose-related) | see BDK List for Paragraph | lowers seizure threshold |